authors pharmaceutical-technology-editors 
European Pharmaceutical Review
JANUARY 12, 2024
A recent survey from the Pistoia Alliance revealed that AI and machine learning (ML) will be the top technology investment for 60 percent of life sciences companies over the next two years. Levy is a leading life sciences expert who has published multiple articles on drug development and technology trends.
European Pharmaceutical Review
JULY 1, 2022
The article, published in the Journal of Validation Technology ( JVT ), presents the case study of a company undergoing an investigation and developing a strategy for identifying worst-case sampling locations on equipment, after a regulatory auditor asked for such a rationale and no written documentation could be provided.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
JUNE 16, 2023
A less-investigated aspect of the recent digital health investment downturn, however, is that not all startups were affected equally, in particular with those focused on the pharmaceutical and life sciences industry faring better in terms of funding and outlook.
pharmaphorum
JULY 27, 2022
Richard Torbett, chief executive at the Association of the British Pharmaceutical Industry (ABPI) said Life Sciences Competitive Indicators (LSCI) data published last week “ought to ring alarm bells across Government”. About the author. Amanda Barrell is a freelance health and medical education journalist, editor and copywriter.
Pharmaceutical Technology
OCTOBER 13, 2022
Colonis then sent a corrective letter to the recipients, but a Prescription Medicines Code of Practice Authority panel pointed out that it didn’t specify this was required by the MHRA. The post UK approves prescription-only melatonin drug for childhood ADHD appeared first on Pharmaceutical Technology.
Expert insights. Personalized for you.
78 
Let's personalize your content